ISTH 2020 Congress Archives - ISTH Congress Abstracts

Abstract Number: PB0347

B Cell Cytokines in Italian Hemophilia A Patients with Inhibitors

B. Doshi^1,2, G. Castaman³, V. Arruda^1,2
Abstract Number: PB0761

B- Mode Ultrasound-Guided Photomechanic-Shock Wave Combination Thrombolytic Therapy of Embolic Artery Accompanied by Simultaneously Streptokinase – Loaded Microbubbles Administration

H. Mehrad¹, M. Farhoudi²
Abstract Number: PB0906

Baropodometric Barefoot Analysis for Musculoskeletal Health Assessment in Congenital Hemophilia

R. Gualtierotti¹, V. Begnozzi², E. Boccalandro², S. Braham², M.E. Mancuso², E. Santagostino², F. Peyvandi^2,3
Abstract Number: PB0234

Baseline VWF Antigen Level Is Associated with the Outcome of Immune Tolerance Induction Using pdFVIII/VWF Concentrate in Hemophilia A with Inhibitor

Z. Li¹, Z. Chen¹, X. Cheng¹, X. Wu¹, G. Li¹, Y. Zhen¹, S. Cai², M.-C. Poon³, R. Wu¹
Abstract Number: PB0544

Basic Evaluation of Novel Automated Coagulation Analyzer CN-6000

R. Narisada¹, N. Nishimura¹, T. Sakayori²
Abstract Number: PB0704

Batroxobin Based Method to Measure Fibrinogen to Overcome Interfering Effects of New Anticoagulant Agents Targeting Thrombin

J. Ha¹, R. Park², M.-S. Yang¹, S.-K. Kim¹, H.-J. Kim¹, Y. Song¹, J. Song¹
Abstract Number: PB0870

BAY 81-8973 prophylaxis in Patients with Hemophilia A: Interim Usage and Safety Results from the TAURUS Real-World Study

C. Santoro¹, M. Wang², B. Fuh³, P. Maes⁴, M.E. Mingot-Castellano⁵, R. Berrueco⁶, E. Detering⁷, J.F. Cabre Marquez⁸, P.Q. Lê⁹
Abstract Number: PB1656

Bcl-Xl Deamidation State Tells Platelets Age

C. James^1,2, C. Bobo^3,4, P. Ganatirkar^5,6, R. Uren^6,7, E. Riviere^1,2, E. Josefsson^5,6, R. Kluck^6,7, M. Priault^3,4
Abstract Number: PB0012

BDNFVal66Met Polymorphism Affects Cardiac Remodeling and Modulates Macrophage Polarization After Myocardial Infarction

L. Sandrini¹, L. Castiglioni², P. Amadio¹, J.P. Werba¹, S. Eligini¹, S. Fiorelli¹, M. Zarà¹, S. Castiglioni³, S. Bellosta³, F.S. Lee⁴, L. Sironi^2,5, E. Tremoli¹, S.S. Barbieri¹
Abstract Number: PB1449

Bernard – Soulier Syndrome (BSS): From Identification of the Variants to their Functional Studies

G. Fontana¹, T. Giangregorio², D. De Rocco², E. Valencic², P. Noris³, S. Barozzi³, V. Bozzi³, C. Balduini⁴, A. Pecci³, F. Lanza⁵, A. Savoia^1,2
Abstract Number: PB0566

Bethesda Assay for the Detection and Titration of an Anti-VIII Inhibitor: Interest of the Chromogenic Assay

C. Nougier, E. Jousselme, F. Sobas, A. Lienhart, C. Négrier
Abstract Number: PB2079

Beyond the Registry: A Nuanced Evaluation of Real World Anticoagulation for Nonvalvular Atrial Fibrillation Patients at a Tertiary Care Center

G. Woodhouse¹, Z. Paschall², C. Lunowa³, J. Burch¹, L. Schilling⁴, M. Rosenberg⁵, N. Mantini⁵
Abstract Number: PB1705

Bile Acids Maintain Platelet Homeostasis via p38 and Akt Pathway

Z. Cheng, X. Zhou, H. Mei, Y. Hu
Abstract Number: OC 04.5

BIN2 Orchestrates Platelet Calcium Signaling in Thrombosis and Thrombo-inflammation

S. Beck^1,2, J. Volz^1,2, T. Voegtle^1,2, M. Popp^1,2, C. Kusch^1,2, M. Meub³, I. Scheller^1,2, J. Preu^1,2, M.K. Schuhmann⁴, T. Premsler^1,2, A. Sickmann^5,6,7, M. Sauer³, D. Stegner^1,2, G. Stoll⁴, A. Braun^1,2,8, B. Nieswandt^1,2
Abstract Number: PB2491

Biological and Pharmacological Profiling of Pentosan Polysulfate (PPS) in Comparison to Heparin and its Relative Neutralization by Protamine Sulfate

V. Venkitasubramony¹, A. Polisky¹, F. Siddiqui¹, A. Kouta¹, J. Fareed¹, D. Hoppensteadt¹, O. Iqbal¹, A. Laddu², W. Jeske¹
Abstract Number: PB/CO11

Biomarkers of COVID-19 Coagulopathy and D-dimer in a Biracial Cohort Study

D. Kamin Mukaz¹, M. Gergi¹, I. Koh¹, N.A. Zakai¹, S.E. Judd², M. Sholzberg³, L. Baumann Kreuziger⁴, K. Freeman¹, C. Colovos¹, M. Cushman¹
Abstract Number: PB1136

Biomarkers of Fibrinolysis Predict the Need for Massive Transfusion in Trauma

A. Ilich¹, M. Ferrara², V. Kumar¹, M. Henderson¹, D. Jenkins³, R. Kozar⁴, M. Park², N.S. Key¹
Abstract Number: PB2008

Biomarkers of Platelet Activation and their Prognostic Value in Patients in Sepsis Associated Coagulopathy

D. Hoppensteadt¹, G. Wegryzn¹, A. Walborn¹, M. Rondina², J. Fareed¹
Abstract Number: PB2131

Biomarkers of Venous Thromboembolism Recurrence After Discontinuation of Anticoagulation for Cancer-Associated Thrombosis (HISPALIS- Study)

J. Oto¹, V. Sánchez-López², E. Arellano-Orden², A. Solier-López³, S. Marín-Romero³, L. Jara-Palomares³, T. Elias-Hernández³, M.I. Asencio-Cruz³, I. Blasco-Esquivias⁴, M. Rodriguez-de-la-Borbolla⁵, J.M. Sánchez-Díaz³, F.J. Rodriguez-Martorell⁶, P. Medina-Badenes¹, R. Otero-Candelera³
Abstract Number: PB0569

Biosimilar Enoxaparin Sodium Inhixa^® Compared with Clexane^®: An in vitro Study

C. Dellanoce¹, O. Paoletti², M. Tala², V. Cancelli², E. Cancellieri², R. Morandini², S. Zambelli², M.C. Beati², M. Stramezzi², V. Castellani², S. Testa²
Abstract Number: PB0214

Bisecting the Role of the C-terminal End of Antithrombin: Natural Variants due to a Frameshift at Different Secondary Structures May Exacerbate or Ameliorate a New Dominant-negative Effect

C. Bravo-Perez¹, M. Toderici¹, B. de la Morena-Barrio¹, J. Padilla¹, A. Miñano¹, A. Palomo², H. Perez-Sanchez³, J. Martinez-Menarguez⁴, J. Chambers⁵, S. Marciniak⁵, V. Vicente¹, J. Corral¹, M.E. de la Morena-Barrio¹
Abstract Number: PB1314

Bivalirudin Administration in Pediatric Ventricular Assist Devices and in Pediatric ECMO

C. Giorni^1,2, A. Rizza¹, S. Benegni¹, I. Favia¹, L. Vallesi³, D. Selvaggio⁴, A. Amodeo⁵, L. Di Chiara¹, Z. Ricci¹
Abstract Number: PB1292

Bivalirudin as the Primary Anticoagulant for Pediatric Patients with a Berlin EXCOR Ventricular Assist Device (VAD)

M. Silvey¹, A. Barnes², S. Carpenter¹
Abstract Number: PB0310

Bleeding and Thrombotic Complications in Patients Undergoing Major Cardiac Surgery on Single, Dual Antiplatelet Treatment Compared to Controls

C. Little¹, T. Aw², R. Szydlo³, M. Laffan¹, D. Arachchillage^1,4
Abstract Number: PB1063

Bleeding Outcomes, Factor Utilization and Cost Comparisons after Switching to an Extended Half-life Product for Prophylaxis in Haemophilia A in Austria

C. Ay¹, C. Feistritzer², J. Rettl³, G. Schuster⁴, A. Vavrovsky⁵, I. Pabinger¹
Abstract Number: PB2124

Bleeding Risk Assessment Model for Older Multiple Myeloma Patients on Immunomodulatory Drugs (IMIDs)

A. Li¹, G. Warnick², E. Libby³, D. Garcia³, G. Lyman²
Abstract Number: PB1475

Bleeding Symptoms Associated with Platelet Function Abnormalities on Ibrutinib Therapy

A.A. Ignatova¹, E.A. Nikitin², E.A. Dmitrieva², V.I. Vorobyev², A.V. Poletaev¹, E.A. Seregina¹, D.M. Polokhov¹, A.A. Maschan¹, G.A. Novichkova¹, V.V. Ptushkin², M.A. Panteleev^1,3,4
Abstract Number: PB0322

Bleeds and Imaging Scores in Relation to Pharmacokinetics of Coagulation Factor VIII in Chinese Pediatric Patients with Severe Hemophilia A

H. Kun, Z. Chen, G. Li, R. Wu, Y. Zhen, N. Zhang
Abstract Number: PB1179

Blocking Tissue Factor Pathway Inhibitor (TFPI) Function Has a Therapeutic Benefit in Murine Models of Factor Deficiencies

L. Ivanciu^1,2, J.R. Crosby³, A.S. Revenko³, R.J. Davidson¹, R.M. Camire^1,2
Abstract Number: PB0708

Blood Compatibility of Injectables Liposomes Encapsulating Estrogen Estetrol to Prevent Cerebral Ischemia of Prematurity

J. Laloy¹, C. Palazzo², A.-S. Delvigne¹, G. Piel², J. Douxfils³, J.-M. Foidart⁴, J.-M. Dogné^1,3
Abstract Number: PB0833

Bone Remodeling Alterations in Haemophilia: A Cell Biology Approach

S. Lancellotti¹, G. Battafarano², M. Sacco³, L. Di Gennaro¹, R. De Cristofaro^1,3, A. Del Fattore²
Abstract Number: PB2258

Budd Chiari Syndrome: Beyond 5 Years of Follow up

D. Mezzarobba¹, N. Schutz², D. Penchasky¹, E. Viñuales¹, V. Privitera¹, F. Chuliber¹, M. Villagra Iturre¹, J. Bandi³, E. Nucifora¹